SPY319.40+8.04 2.58%
DIA271.51+8.18 3.11%
IXIC9,814.08+198.27 2.06%

Citigroup Maintains Buy on MyoKardia, Raises Price Target to $125

Citigroup maintains MyoKardia (NASDAQ:MYOK) with a Buy and raises the price target from $87 to $125.

Benzinga · 05/12/2020 16:08

Citigroup maintains MyoKardia (NASDAQ:MYOK) with a Buy and raises the price target from $87 to $125.